Mode
Text Size
Log in / Sign up

Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damageOxidative stress and nerve damage drive glaucoma progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that oxidative stress and ROS are key mediators of retinal ganglion cell death and optic nerve damage in glaucoma.

This narrative review examines the role of oxidative stress and reactive oxygen species (ROS) in the pathogenesis of glaucoma. The authors synthesize evidence identifying ROS as key mediators of retinal ganglion cell (RGC) death and optic nerve (ON) damage. The review highlights how these processes contribute to mitochondrial dysfunction, neuroinflammation, synaptic instability, and altered neurotrophic signaling.

To investigate these mechanisms, the review synthesizes data from multiple experimental platforms. In vitro systems, including TM cells and iPSC-derived models, allow for the study of ROS-induced stress and the screening of potential therapeutic agents. In vivo models, such as microbead-induced OHT and genetic models, provide insights into oxidative stress within the context of raised IOP, neuroinflammation, and vascular dysregulation. Additionally, human donor tissues and clinical biospecimens provide translational support by demonstrating oxidative damage in glaucomatous eyes.

The authors note that the review is not fully comprehensive. The findings suggest that these experimental platforms can guide model selection for studying ROS-mediated mechanisms and developing neuroprotective strategies. The evidence regarding the association of oxidative stress with glaucoma-related cellular and molecular changes is currently established through these diverse models.

How this fits prior evidence

This narrative review addresses a gap in the understanding of underlying mechanisms of glaucoma by identifying oxidative stress and ROS as key mediators of retinal ganglion cell death and optic nerve damage. While previous coverage has focused on clinical outcomes, such as the 25.6% incidence of postoperative glaucoma after certain keratoprosthesis implants or the 86% sensitivity of portable visual-field testing devices, this review focuses on the cellular and molecular drivers of the disease.

Living with glaucoma means facing a constant threat to your vision. Scientists have identified a specific process called oxidative stress as a key driver of the damage. This happens when reactive oxygen species (ROS) harm the cells in the retina and the optic nerve, which are vital for sight.

To understand this better, researchers looked at several different models. They used lab-grown cells and human tissue samples to see how these molecules cause damage. They also used animal models to see how high eye pressure and inflammation work together to hurt the nerves. These different methods help scientists pinpoint exactly how the disease progresses.

While this research is not yet a complete overview of every possible factor, it highlights important ways to study the disease. By using these different models, scientists can better test new ways to protect nerves and slow down vision loss. These findings provide a clearer map for developing future treatments.

What this means for you:
Oxidative stress and reactive oxygen species are key factors in damaging the optic nerve in glaucoma patients.

Common questions

What role does oxidative stress play in glaucoma?

Oxidative stress and reactive oxygen species (ROS) are identified as key mediators of retinal ganglion cell death and optic nerve damage. These processes are linked to the cellular and molecular changes seen in glaucoma. Because these factors contribute to nerve damage, they are important targets for developing new ways to protect the eyes.

How do researchers study these effects in the lab?

Researchers use several methods to study these issues. They use in vitro systems like cell cultures to study cellular processes in controlled ways. They also use in vivo models to study how high eye pressure and inflammation affect the nerves, and human donor tissues to see how oxidative damage appears in real glaucomatous eyes.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Glaucoma is a complex optic neuropathy and the leading cause of permanent blindness worldwide. Elevated intraocular pressure (IOP) is the major modifiable risk factor for this disease. Growing evidence suggests that oxidative stress and reactive oxygen species (ROS) are key mediators of retinal ganglion cell (RGC) death and optic nerve (ON) damage. In this review, we summarize experimental models that are routinely used to study oxidative stress in glaucoma and discuss the translational value of each model system for biomarker discovery and treatment development. This narrative review focuses on studies that emphasize experimental and clinical models relevant to oxidative stress in glaucoma. Primary experimental and clinical studies that directly investigated pathways of oxidative stress in glaucoma models were included for contextual synthesis. In vitro systems such as TM cells, RGCs, and induced pluripotent stem cell (iPSC)-derived models enable controlled conditions to study cellular processes of ROS-induced stress and to screen potential therapeutic agents. Three-dimensional culture systems provide even more physiological insights by replicating retinal development, organization, and function. In vivo models include microbead-induced ocular hypertension (OHT), episcleral vein cauterization (EVC), and genetic models, allowing for the study of oxidative stress in the context of raised IOP, neuroinflammation, and vascular dysregulation. Findings from human donor tissues and clinical biospecimens provide translational support for experimental models by showing oxidative damage in glaucomatous eyes. Across model systems, oxidative stress is associated with glaucoma-related cellular and molecular changes, including mitochondrial dysfunction, neuroinflammation, synaptic instability, and altered neurotrophic signaling. This review provides a structured, model-based overview of how oxidative stress can be investigated across in vitro, in vivo, and clinical systems for glaucoma research. Although it is not intended to be fully comprehensive, it highlights key experimental platforms that can guide model selection for studying ROS-mediated mechanisms and developing neuroprotective strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.